If you’re a new parent, you’re likely worried about all the potential medical issues that might arise. In most cases, there’s ...

Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

Following this, Luke Coutinho shares a list of eight foods scientifically backed to fuel stem cells and maximize overall health. These vegetables contain compounds that help neutralize toxins and ...

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023.Pipeline progress included the approval ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital ...

Dr. Finlay discusses how cellular metabolism affects NK cell responses to tumors and viral infections, highlighting how metabolic engineering can improve NK cell function in challenging ...